Early research (Phase 1)Study completedNCT01568775
What this trial is testing
Pharmacokinetics, Safety and Tolerability of Aliskiren (SPP100) in Patients With End Stage Renal Disease on Hemodialysis and Matched Healthy Subjects
Who this might be right for
End Stage Renal Disease
Novartis 12